CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 58 enrolled
Drug / intervention
Parecoxib +1 moredrug
Likely dose
Parecoxib 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05150431
NCT05150431Phase 4Completed

Perioperative Pain-control With Parecoxib in Uniportal Video-assisted Thoracoscopic Surgery.

National Taiwan University Hospital·interventional·Posted Dec 9, 2021·Updated Aug 2, 2023

In Brief

A Phase 4 clinical trial evaluating Parecoxib and Placebo for Perioperative Care and Chronic Post-operative Pain. Completed, enrolled 58 participants across 1 site.

Detailed Summary

Chronic pain after thoracic surgery has been a bothering problem since the era of thoracotomy. The prevalence of chronic pain no matter in thoracotomy or video-assisted thoracoscopic surgery is about 30 to 47%. Better acute pain control after thoracic surgery has been assumed to be an effective way for prevention of chronic pain. Especially in this extreme minimal invasive surgery, uniportal video-assisted thoracic surgery, more optimized perioperative analgesics should be found out. In the guideline of "enhanced recovery after surgery", less opioid is suggested. Other than opioids, there are just few parental analgesics could be used, like acetaminophen or cyclooxygenase-2(COX-2) inhibitor. In our study, the investigators would like to build up a better analgesic strategy for uniportal video-assisted thoracoscopic surgery with less opioid and less side effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTaiwan
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedDec 9, 2021
Enrollment StartDec 15, 2021
Primary CompletionMay 1, 2022
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 4.6 years ago

Interventions

Parecoxibdrug

Parecoxib 40mg will be administered to the experimental group if the patient has no contraindication.

Placebodrug

This is normal saline 2ml, which is equal to the volume of parecoxib solution. Placebo will be injected to placebo group 15 minutes before the end of the surgery.